Diana Escolar
CIK 1797269 · View on SEC EDGAR ↗
First SEC filing: Jan. 22, 2021 · Latest: Jan. 22, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 10, 2021 | TECX | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 1, 2021 | TECX | A | 130,000 | — | — | 130,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 12, 2020 | VRDN | A | 270,000 | — | — | 270,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 10, 2021 | TECX | Stock Option (Right to Buy) | Common Stock (50,000) | $9.63 | June 9, 2031 | 50,000 | Acquired |
| Feb. 1, 2021 | TECX | Stock Option (Right to Buy) | Common Stock (130,000) | $14.55 | Jan. 31, 2031 | 130,000 | Acquired |
| Feb. 12, 2020 | VRDN | Stock Option (right to buy) | Common Stock (270,000) | $0.80 | Feb. 11, 2030 | 270,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
VRDN
M.D.Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $417,473 | $277,780 | — | $164,492 | — | — | $5,873 | $865,618 |
| 2019 | $372,600 | $111,780 | — | $59,408 | — | — | — | $543,788 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.